SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
化学名称: (2RS)-N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)amino]propyl]-N-methyloxolan-2-carboxamide hydrochloride (as per EP)
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
微笑: O=C(C1OCCC1)N(CCCNC2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)C.Cl
Alfuzosin EP Impurity C Hydrochloride is chemically (2RS)-N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)amino]propyl]-N-methyloxolan-2-carboxamide hydrochloride (as per EP). Alfuzosin EP Impurity C Hydrochloride is supplied with detailed characterization data compliant with regulatory guideline. Alfuzosin EP Impurity C Hydrochloride can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Alfuzosin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Stability-indicating HPTLC method for the simultaneous detection and quantification of alfuzosin hydrochloride, solifenacin succinate along with four of their official impurities
Mahmoud A. Tantawy, Soheir A. Weshahy, Mina Wadie , Mamdouh R. Rezk
Microchemical Journal Volume 157, September 2020, 104905
An improved and commercially viable process for the preparation of Alfuzosin hydrochloride
Manne Satyanarayana Reddy*a , Bairy Kondal Reddya , Chepyala Kista Reddyb , Muppa Kishore Kumara , Srinivasan Thirumalai Rajana and Venkatesh Mummadi
ARKIVOC 2007 (xiii) 41-46
Thermoanalytical study of alfuzosin hcl
Ali k. attia1,*, nagiba y. hassan2, a. el-bayoumi2, samar. g. abdel-hamid1
Int J Curr Pharm Res, Vol 4, Issue 3, 101-105